Theriva Biologics (AMEX:TOVX) is set to give its latest quarterly earnings report on Thursday, 2023-05-11. Here’s what investors need to know before the announcement.
Analysts estimate that Theriva Biologics will report an earnings per share (EPS) of $-0.32.
Theriva Biologics bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Stock Performance
Shares of Theriva Biologics were trading at $0.7256 as of May 09. Over the last 52-week period, shares are down 26.01%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Theriva Biologics visit their earnings calendar on our site.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
